| Patents for C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931) |
|---|
| 04/08/2008 | US7355046 Chronic obstructive pulmonary dusease; asthma |
| 04/08/2008 | US7354926 Molecules derived from noraporphine |
| 04/08/2008 | US7354925 Alpha aryl or heteroaryl methyl beta piperidino propanamide compounds as ORL1-receptor antagonists |
| 04/03/2008 | WO2008037784A1 Quinolinone derivatives |
| 04/03/2008 | US20080081822 N-(5-tert-Butyl-isoxazol-3-yl)-2-cyclohexanesulfonyl-2-methyl-propionamide; cannabinoid receptor agonist, antagonist; analgesic, antiinflammatory and antitumor agent; neuropatic pain |
| 04/03/2008 | US20080081812 and inverse agonist; 2-(5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazol-3-yl)-5-(pyridin-4-yl)-1,3,4-oxadiazole; obesity and obesity-related metabolic disorders |
| 04/03/2008 | CA2660377A1 Quinolinone derivatives |
| 04/02/2008 | EP1904449A2 Inhibitors of checkpoint kinases |
| 04/02/2008 | CN100378078C Tetrahydro quinoline compound and its synthesizing process as catalysted by Lewis acid |
| 04/01/2008 | CA2279293C Hexahydroindenopyridine compounds having antispermatogenic activity |
| 03/27/2008 | WO2007092879A3 Substituted thiatriazaacenaphthylene-6-carbonitrile kinase inhibitors |
| 03/27/2008 | US20080076928 Novel pharmaceutical salts of 1-benzyl-4-[ (5,6-dimethoxy-1-indanone)-2-yl] methyl piperidine ( Donepezil) |
| 03/27/2008 | US20080076784 Bicyclic, Nitrogen-Containing Heterocycles and Aromatase Inhibitors |
| 03/27/2008 | US20080076781 Pseudobase benzo[c]phenanthridines with improved efficacy, stability, and safety |
| 03/27/2008 | US20080076762 Novel 4-Aminopiperidine Derivatives |
| 03/27/2008 | US20080076755 4-(Adamantane-1-carbonylamino)-3-oxo-2-aza-bicyclo[2.2.2]octane; 5-(Adamantane-1-carbonylamino)-10-oxo-9-aza-bicyclo[3.3.2]decane for treating autoimmune diseases, vascular disorders, viral infection or replication, asthma, osteoporosis, tumor growth, rheumatoid arthritis, organ transplant rejection |
| 03/27/2008 | US20080076188 Luminescent compounds |
| 03/26/2008 | CN101151250A Processes for preparing morphinans and intermediates thereof |
| 03/26/2008 | CN101151249A Cyclopentapyridine and tetrahydroquinoline derivatives |
| 03/26/2008 | CN101148437A Biinomenine derivative connected with C-C bond, preparation method and application thereof |
| 03/26/2008 | CN100376571C 6-substituted pyrido-pyrimidines |
| 03/25/2008 | US7348431 Receptor or non-receptor; 5,6,7,8,9,10-hexahydro-6,9-(epiminomethano) benzo[ alpha ][8]annulenes; anticarcinogenic, antidiabetic, antiproliferative agents; autoimmune and Crohn's diseases, acromegaly, aging resistance; coadminister tamoxifen, raloxifene, taxol, trastuzumab, tirofiban or a COX-2 inhibitor |
| 03/20/2008 | WO2008031772A1 Azabicyclic compounds as inhibitors of monoamines reuptake |
| 03/20/2008 | WO2008031771A2 3-azabicyclo [4. 1. 0] heptane derivatives for the treatment of depression |
| 03/20/2008 | WO2008005910A3 Pyridone/hydroxypyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors |
| 03/20/2008 | WO2007072092A8 New phenanthridine derivatives as bradykinin antagonists |
| 03/20/2008 | US20080070903 New pyrimidine derivatives and new pyridine derivatives |
| 03/20/2008 | CA2662538A1 Azabicyclic compounds as inhibitors of monoamines reuptake |
| 03/19/2008 | EP1899303A1 Novel 3-aza-spiro[5.5]undecane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 03/19/2008 | EP1899301A1 Novel 3-aza-spiroý5.5¨undec-8-ene derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 03/19/2008 | CN101143847A Synthesis method for tartaric acid lappaconitine |
| 03/18/2008 | US7345174 Selectively inducing terminal differentiation of neoplastic cells; antiproliferative agents; antineoplastic agents; antitumor agents; melanomes; acute leukemia, multiple myeloma; carcinomas; neuroblastoma; N-t-butoxycarbonyl- omega -methyl - alpha -aminosuberateanilide |
| 03/18/2008 | US7345052 Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods |
| 03/13/2008 | WO2007136570A3 5,6-fused pyrrolidine compounds useful as tachykinin receptor antagonists |
| 03/13/2008 | US20080064875 Colorant compounds |
| 03/13/2008 | US20080064838 Such as (3-(2-pyridyl-1-methylethyl)indenyl)chromium dichloride for catalytic addition polymerization |
| 03/13/2008 | US20080064726 Dipeptidyl peptidase-IV (DPP-IV) inhibitor; diabetes mellitus, insulin-resistant diseases, obesity, hypoglycemia ; 2-[4-({2-[(2S,4S)-2-cyano-4-fluoropyrrolidin-1-yl]-2-oxoethyl}amino)-4-methylpiperdin-1-yl]-2-oxoethyl acetate monofumarate |
| 03/13/2008 | US20080064690 Neuropathic or inflammatory pain relief; inhibiting ion flux through channel including PN3 subunit; potency |
| 03/12/2008 | EP1896422A2 Tyrosine kinase inhibitors |
| 03/12/2008 | EP1896421A2 Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase met |
| 03/12/2008 | EP1896014A2 Chemical compounds |
| 03/12/2008 | CN101139321A Method for separating and purifying nuciferine by employing cationic ion-exchange resin |
| 03/12/2008 | CN101139320A Method for separating nuciferine and lotus leaf flavone from lotus leaf |
| 03/11/2008 | US7342024 4-Oxo-1-3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitors |
| 03/11/2008 | US7342016 Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives; use in combination with antineoplastic agents such as cisplatin |
| 03/06/2008 | WO2008002614A3 Pseudoazulenyl nitrones |
| 03/06/2008 | WO2007100664A3 Modulators of muscarinic receptors |
| 03/06/2008 | US20080058528 Synthesis of (2S,5R)-5-ethynyl-1-{N-(4-methyl-1-(4-carboxy-pyridin-2-yl)piperidin-4-yl)glycyl}pyrrolidine-2-carbonitrile |
| 03/06/2008 | US20080058526 Halogenation of Rylen-Carboximides with Elementary Halogene in a Two-Phase Mixture Comprising an Organic Solvent and Water, Wherein Formed Halogene Hydrocide is Continously Removable from the Organic Solvent |
| 03/06/2008 | US20080058525 Novel dye complexes and use thereof in imaging members and methods |
| 03/06/2008 | US20080058365 Fused heterocyclic compounds |
| 03/06/2008 | US20080058329 Novel indane compounds |
| 03/06/2008 | US20080058311 Antagonizing N-type calcium channels; use as analgesic, neurodegenerative diseases, brain injury, bronchial asthma, unstable angina and irritable colitis, drug withdrawal symptoms; t-butyl 2-[4-(5H-dibenzo[a,d][7]annulen-5-ylidene)-1-piperidinyl]-2-oxoethylcarbamate for example |
| 03/06/2008 | CA2661842A1 Serine-threonine protein kinase and parp modulators |
| 03/05/2008 | EP1732541A4 Cyclic compounds |
| 03/05/2008 | EP1383733B1 Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds |
| 03/05/2008 | CN101137377A Tetracyclic amino and carboxamido compounds and methods of use thereof |
| 03/05/2008 | CN101134757A 稠合杂环化合物 Fused heterocyclic compounds |
| 03/05/2008 | CN101134743A Method for extracting and separating Huperzine from huperzine serrate |
| 03/05/2008 | CN100372855C 7-imino derivatives of camptothecin having antitumor activity |
| 03/05/2008 | CN100372848C Spiroazacyclic compounds as monoamine receptor modulators |
| 03/05/2008 | CN100372846C Sulfonamido substituted imidazopyridines |
| 03/05/2008 | CN100372839C Method for preparing bicycloenyl lactan |
| 02/28/2008 | WO2007016136A3 Organic nitric oxide enhancing salts of cyclooxygenase-2 selective inhibitors, compositons and methods of use |
| 02/28/2008 | US20080051434 Hemiasterlin derivatives and uses thereof in the treatment of cancer |
| 02/28/2008 | US20080051416 Novel Compounds |
| 02/28/2008 | US20080050795 Mixture Of At Least Two Different Antibodies Specific For Predetermined Antigens And Use Of The Mixture |
| 02/28/2008 | US20080050761 Sox-based kinase sensor |
| 02/28/2008 | CA2661503A1 Inhibitors of 11.beta. -hydroxysteroid dehydrogenase type 1 |
| 02/27/2008 | EP1892239A1 Inhibitors of cytosolic phospholipase A2 |
| 02/27/2008 | EP1891073A1 Novel substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives and their use as a medicament |
| 02/27/2008 | EP1891013A1 Tetrahydroquinoline derivatives |
| 02/27/2008 | EP1891011A1 Tetrahydroquinolines used in the form of modulators of mitotic motor-proteins eg5 |
| 02/27/2008 | EP1890696A2 Novel 3-spirocyclic indolyl derivatives useful as orl-1 receptor modulators |
| 02/27/2008 | CN101130520A Novel method for splitting and producing natural (-)-huperzine and non- natural (+)-huperzine by racemate of diastereoisomer salt |
| 02/27/2008 | CN100370987C Tartrate salt of 5,8,14-triazatetracyclo [10,3,1,02,11.04,9]-hexzdeca-2(11),3,5,7,9-pentaene |
| 02/26/2008 | US7335771 6-{2,9-Dinitro-12-(5-carboxypentyl)-7,14-dioxo-7,14-dihydro-12H-quino[2,3-b]acridin-5-yl}hexanoic acid, diethyl ester to label and identify preferential biopolymer in solution |
| 02/26/2008 | US7335665 Spirocyclic piperidines as MCH1 antagonists and uses thereof |
| 02/21/2008 | WO2008021694A1 Anthrapyridone compounds |
| 02/21/2008 | US20080045715 Preparation of Opiate Analgesics by Reductive Alkylation |
| 02/21/2008 | US20080045713 Tetrahydroisoquinolinedione derivative intermediates for the hemisynthesis of ecteinascidin or other tetrahydroisoquinolinephenol compounds |
| 02/21/2008 | US20080045557 Compounds and methods to inhibit or augment an inflammatory response |
| 02/21/2008 | US20080045539 such as 5-{5-[(endo)-8-methyl-8-aza-bicyclo[3.2.1]oct-3-yloxy]-pyridin-2-yl}-1H-indole, having nicotinic receptors modualtory activity, used for the treatment of attention deficit disorder, senile dementia, Down's syndrome, amyotrophic lateral sclerosis, Huntington's, Pick's and Alzheimer's disease |
| 02/21/2008 | US20080045538 Nitro and amino substituted topoisomerase agents |
| 02/21/2008 | US20080045537 Chemical Compounds |
| 02/21/2008 | US20080045517 Such as {(2S)-2-[2-[2-(7-azabicyclo[2.2.1]hept-7-yl)-1,1-dimethyl-2-oxoethyl]-5-(3,5-dimethylphenyl)-6H-thieno[2,3-b]pyrrol-4-yl]propyl}(2-pyridin-4-ylethyl)amine for treating sex hormone related prostate cancer and pre-menopausal breast cancer |
| 02/21/2008 | US20080045503 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 02/21/2008 | US20080045500 Nerve Regeneration Stimulator |
| 02/21/2008 | US20080044379 (1R)-2-((2S)-2-(5-(6-(4-(2-((2S)-1-((2R)-2-(dimethylamino)-2-phenylacetyl)-2-pyrrolidinyl)-1H-imidazol-5-yl)phenyl)-3-pyridinyl)-1H-imidazol-2-yl)-1-pyrrolidinyl) -N,N-dimethyl-2-oxo-1-phenylethanamine; inhibit the function of the non-structural proteins (NS5A) |
| 02/20/2008 | EP0644877B1 Substituted-hexahydrobenzo a phenanthridines |
| 02/19/2008 | US7332503 Aporphine esters and their use in therapy |
| 02/19/2008 | US7332502 Phenanthroindolizidine alkaloids |
| 02/14/2008 | US20080039490 Pyridines for treating injured mammalian nerve tissue |
| 02/14/2008 | US20080039488 Salt of naphthyridine carboxylic acid derivative |
| 02/14/2008 | US20080039472 Inhibitors of the Interaction Between Mdm2 and P53 |
| 02/14/2008 | US20080039460 2-Chloro-N-(2-thiophen-2-yl-3H-imidazo[4,5-b]pyridin-6-yl)-benzamide; cancer |
| 02/14/2008 | US20080039446 Substituted isoindoles and their use |
| 02/14/2008 | US20080038390 Alkaloid compounds and their use as anti-malarial drugs |
| 02/14/2008 | US20080038242 sodium-dependent nucleoside transporter 2 inhibitors; for diseases associated with abnormal plasma uric acid levels such as gout, hyperuricemia, urinary lithiasis, hyperuriciemic nephropathy, and acute uric acid nephropathy |
| 02/13/2008 | EP1044189B1 Aryl fused azapolycyclic compounds |